ArticleJournal for immunotherapy of cancer2026

FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

Thuy Trinh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.